Table 1 Baseline characteristics at admission to in-patient rehabilitation and pharmacotherapy of patients with or without MAU
|  | Total (n = 1,167) | MAU (+) (n = 386) | MAU (−) (n = 781) | p-value |
|---|---|---|---|---|
Age, mean years ± SD | 66 ± 11.9 | 69 ± 11.1 | 65 ± 12.5 | < 0.0001 |
Male gender (%) | 58.1 | 55.7 | 59.4 | 0.33 |
Body Mass Index (mean kg/m2 ± SD) | 27.5 ± 4.7 | 27.8 ±5.2 | 27.1 ±1.5 | 0.03 |
Diabetes (%) | 34.6 | 41.8 | 20.1 | < 0.0001 |
Hypertension (%) | 79.3 | 80.2 | 78.9 | 0.09 |
Hyperlipidemia (%) | 80.3 | 81.3 | 79.7 | 0.08 |
Smoking | ||||
Current (%) | 18.4 | 17.7 | 18.7 | 0.93 |
Previous (%) | 38.8 | 39.2 | 38.7 | 0.93 |
mean packs*years ± SD | 32.1 ± 26.4 | 33.1 ± 27.8 | 31.9 ± 27.1 | 0.65 |
Waist circumference (%) | ||||
men (% ≥ 102 cm) | 44.4 | 46.8 | 43.2 | 0.04 |
women (% ≥ 88 cm) | 40.9 | 79.5 | 50.4 | <0.0001 |
Blood pressure | ||||
systolic (mean mmHg ± SD) | 134 ± 17 | 136 ± 18 | 132 ± 17 | 0.017 |
diastolic (mean mmHg ± SD) | 77 ± 11 | 77 ± 12 | 77 ± 10 | 0.75 |
Laboratory parameters (%) | Â | Â | Â | Â |
Total cholesterol (mg/dl) | 182 ± 46 | 178 ±47 | 184 ± 44 | 0.06 |
HDL-cholesterol (mg/dl) | 48 ± 15 | 44 ±13 | 49 ± 17 | 0.0002 |
LDL-cholesterol (mg/dl) | 107 ± 17 | 107 ± 21 | 107 ± 15 | 0.91 |
Triglycerides (mg/dl) | 146 ± 71 | 145 ± 73 | 149 ± 69 | 0.63 |
Pharmacotherapy | ||||
Lipid lowering agents (%) | 64.6 | 66.1 | 63.9 | 0.49 |
ARB/ACEi (%) | 45.9 | 56.2 | 40.9 | 0.0002 |
Betablocker (%) | 46.2 | 45.2 | 46.7 | 0.23 |
Calciumantagonists (%) | 29.9 | 24.8 | 27.9 | 0.09 |
Insulin | 5.6 | 8.2 | 4.2 | 0.0003 |
Oral antidiabetic drugs | 14.3 | 23.3 | 9.8 | 0.0002 |
Functional assessment | ||||
NIH Stroke Scale (median, range) | 3 (0–25) | 3 (0–20) | 3 (0–25) | 0.379 |
Barthel Index (median, range) | 85 (0–100) | 75 (0–100) | 90 (0–100) | <0.0001 |
Origin of Stroke (TOAST) | ||||
Large artery atherosclerosis | 41.4 | 53.7 | 35.4 | <0.0001 |
Cardioembolic | 21.8 | 22 | 21.6 | 0.456 |
Small vessel disease | 18.9 | 13.7 | 21.4 | 0.01 |
Other aetiology | 4.5 | 2.4 | 5.5 | 0.234 |
Undetermined aetiology | 13.4 | 8.2 | 16.1 | 0.006 |